JP2002511748A - アポトーシス誘導性ゲルゾリン配列 - Google Patents

アポトーシス誘導性ゲルゾリン配列

Info

Publication number
JP2002511748A
JP2002511748A JP55050798A JP55050798A JP2002511748A JP 2002511748 A JP2002511748 A JP 2002511748A JP 55050798 A JP55050798 A JP 55050798A JP 55050798 A JP55050798 A JP 55050798A JP 2002511748 A JP2002511748 A JP 2002511748A
Authority
JP
Japan
Prior art keywords
gelsolin
nucleic acid
sequence
cells
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP55050798A
Other languages
English (en)
Japanese (ja)
Inventor
コス，カーストン
コサコタ，スリニバス
ティー． ウイリアムズ，ルイス
ラインハート，クリストフ
Original Assignee
カイロン コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カイロン コーポレイション filed Critical カイロン コーポレイション
Publication of JP2002511748A publication Critical patent/JP2002511748A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP55050798A 1997-05-19 1998-05-18 アポトーシス誘導性ゲルゾリン配列 Pending JP2002511748A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4708097P 1997-05-19 1997-05-19
US60/047,080 1997-05-19
PCT/US1998/010181 WO1998052597A1 (fr) 1997-05-19 1998-05-18 Sequences de gelsoline induisant l'apoptose

Publications (1)

Publication Number Publication Date
JP2002511748A true JP2002511748A (ja) 2002-04-16

Family

ID=21946967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55050798A Pending JP2002511748A (ja) 1997-05-19 1998-05-18 アポトーシス誘導性ゲルゾリン配列

Country Status (4)

Country Link
EP (1) EP1003543A4 (fr)
JP (1) JP2002511748A (fr)
AU (1) AU7578498A (fr)
WO (1) WO1998052597A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012531396A (ja) * 2009-06-29 2012-12-10 ヒュテスト アエルテーデー． 診断方法のためのｉｇｆｂｐ−４断片の検出

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6162999A (en) * 1998-09-24 2000-04-10 Promega Corporation Apoptosis marker antibodies and methods of use
EP1173486A1 (fr) * 1999-04-15 2002-01-23 Merck Frosst Canada & Co. Anticorps reconnaissant l'app clivee par les caspases et leurs procedes d'utilisation
JP2007513635A (ja) * 2003-12-12 2007-05-31 バイエル・フアーマシユーチカルズ・コーポレーシヨン 遺伝子発現プロファイルおよび使用方法
WO2007079312A2 (fr) * 2005-12-02 2007-07-12 Regents Of The University Of Colorado Compositions et procédés de traitement d’affections pathologiques médiées par l'actine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0526544T3 (da) * 1990-04-11 1999-06-21 Brigham & Womens Hospital Terapeutiske anvendelser af actinbindende forbindelser

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012531396A (ja) * 2009-06-29 2012-12-10 ヒュテスト アエルテーデー． 診断方法のためのｉｇｆｂｐ−４断片の検出
US9012610B2 (en) 2009-06-29 2015-04-21 Hytest Ltd. Diagnostic kit for IGFBP-4 proteolytic fragments in a patient sample
US9964549B2 (en) 2009-06-29 2018-05-08 Hytest Ltd. Method for detection of IGFBP-4 fragments

Also Published As

Publication number Publication date
AU7578498A (en) 1998-12-11
WO1998052597A1 (fr) 1998-11-26
EP1003543A1 (fr) 2000-05-31
EP1003543A4 (fr) 2001-09-19

Similar Documents

Publication Publication Date Title
WO1999033980A2 (fr) Membres de familles de tnf et de tnfr
WO2000060079A9 (fr) Nouveaux membres des familles tnf et tnfr
JP2001503635A (ja) Ｆａｓリガンドの変異体形態およびその使用
CA2561696A1 (fr) Proteine de modification de galectine-9 novatrice et utilisation de celle-ci
US7566559B2 (en) Human cyclin-dependent kinase (hPNQALRE)
EP1767634A1 (fr) Nouvelle proteine de modification galectine 8 et utilisation de celle-ci
KR20070107152A (ko) 항종양제로서의 ｎｏｄ1
JP2002511748A (ja) アポトーシス誘導性ゲルゾリン配列
JP2002508658A (ja) 野生型ｈｕＢＵＢ１遺伝子の減少の検出
CN101287501A (zh) 作为抗肿瘤剂nod1
US5914266A (en) Mammallian sex comb on midleg (mammalian SCM) acts as a tumor suppressor
US5948640A (en) Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor
JP2000510693A (ja) 哺乳動物の中肢性コーム（哺乳動物Ｓｃｍ）は腫瘍サプレッサーとして作用する
US6174679B1 (en) CIF150/hTAFII150 is necessary for cell cycle progression
WO1999033990A1 (fr) CHEMOKINE HUMAINE CXC (Tim-1)
WO1999019489A1 (fr) POLYNUCLEOTIDES, POLYPEPTIDES ET COMPOSITIONS DE LA PROTEINE MYOSINE IXa ET DE LA PROTEINE DE CANAL 15 A PORTE NUCLEOTIDIQUE CYCLIQUE (CNGC-15), ET PROCEDES ET UTILISATIONS CORRESPONDANTS
WO1999033986A1 (fr) ENHANCER OF POLYCOMB (epc) DE MAMMIFERE SUPPRESSEUR DE TUMEURS
WO1999000499A1 (fr) Proteine humaine interagissant avec fadd (fip)
WO1999033985A2 (fr) LA CIF150/hTAFII150, NECESSAIRE POUR LA PROGRESSION DU CYCLE CELLULAIRE
WO1998057985A2 (fr) Facteur d'interaction avec la proteine rip humaine (rif)
US20040102620A1 (en) Msh4 gene splicing variant delta
WO1999029850A1 (fr) LA PROTEINE KISMET HUMAINE (hkis) AGIT COMME UN ONCOGENE
WO1999029851A1 (fr) Proteine 'kismet' humaine hkis agissant comme suppresseur de tumeur